Apollo Global Management's (APO) Novolex has agreed to buy Pactiv Evergreen (PTVE) for $18 per share in an all-cash deal valued at $6.70 billion, the companies said Monday.
Following deal closure expected in mid-2025, Pactiv Evergreen shares will no longer be listed on the Nasdaq and the combined company will be led by Novolex CEO and Chairman Stan Bikulege, the companies said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。